Full Text
The Full Text of this article is available as a PDF (467.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abraha H. D., Butterworth R. J., Bath P. M., Wassif W. S., Garthwaite J., Sherwood R. A. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem. 1997 Sep;34(Pt 5):546–550. doi: 10.1177/000456329703400510. [DOI] [PubMed] [Google Scholar]
- Aurell A., Rosengren L. E., Karlsson B., Olsson J. E., Zbornikova V., Haglid K. G. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke. 1991 Oct;22(10):1254–1258. doi: 10.1161/01.str.22.10.1254. [DOI] [PubMed] [Google Scholar]
- Bamford J., Sandercock P., Dennis M., Burn J., Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991 Jun 22;337(8756):1521–1526. doi: 10.1016/0140-6736(91)93206-o. [DOI] [PubMed] [Google Scholar]
- Büttner T., Weyers S., Postert T., Sprengelmeyer R., Kuhn W. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke. 1997 Oct;28(10):1961–1965. doi: 10.1161/01.str.28.10.1961. [DOI] [PubMed] [Google Scholar]
- Fassbender K., Schmidt R., Schreiner A., Fatar M., Mühlhauser F., Daffertshofer M., Hennerici M. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci. 1997 May 1;148(1):101–105. doi: 10.1016/s0022-510x(96)05351-8. [DOI] [PubMed] [Google Scholar]
- Takahashi M., Chamczuk A., Hong Y., Jackowski G. Rapid and sensitive immunoassay for the measurement of serum S100B using isoform-specific monoclonal antibody. Clin Chem. 1999 Aug;45(8 Pt 1):1307–1311. [PubMed] [Google Scholar]